Newsroom

Sorted by: Latest

-

Tineco, the Magic of Clean Without the Chore

PARIS--(BUSINESS WIRE)--Tineco today shares its vision of modern cleaning—an approach where technology remains discreet, designed above all to integrate seamlessly into everyday life. Through continuous work on design, ergonomics, and embedded intelligence, the brand pursues a clear objective: to make home care more intuitive, more fluid, and less demanding. In today’s households, innovation is no longer measured solely by technical sophistication, but by how naturally it fits into daily use. F...
-

Tineco, la magie du propre sans la corvée

PARIS--(BUSINESS WIRE)--Tineco partage aujourd’hui sa vision du nettoyage moderne, une approche où la technologie se fait discrète, pensée avant tout pour s’intégrer naturellement dans la vie de tous les jours. Grâce à son travail sur le design, l'ergonomie et l'intelligence embarquée, la marque poursuit un objectif clair : rendre l’entretien de la maison plus intuitif, plus fluide et moins contraignant. Dans les foyers d’aujourd’hui, l’innovation ne se mesure plus uniquement à la sophisticatio...
-

Poxel annonce la mise en place d’une ligne de financement en fonds propres avec IRIS dans le cadre de la mise en œuvre du plan de continuation

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), une société biopharmaceutique en phase clinique développant des traitements innovants pour des maladies chroniques graves à physiopathologie métabolique, notamment la stéatohépatite associée à un dysfonctionnement métabolique (MASH) et les maladies métaboliques rares, annonce la mise à disposition par IRIS d’un financement (dit « SmartATM® ») d’un montant maximum de 5 millions d’euros sur 5 ans (dont les...
-

Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, announces the implementation of an equity line with IRIS, known as “SmartATM® “ for a maximum amount of €5 million over five years (terms set out in the Appendix without this...
-

Arkema and Senior Strengthen Cooperation to Advance Next-Generation Battery Materials

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Arkema (Paris:AKE), a global leader in Specialty Materials, and Senior, a global leader in battery separators technologies, have signed a Memorandum of Understanding (MoU) to further strengthen their long-term strategic cooperation and jointly advance innovation across the battery value chain. Under this strategic collaboration, Arkema and Senior will deepen their technical, commercial, and application-focused cooperation related to Arkema’s c...
-

ARKEMA ET SENIOR RENFORCENT LEUR COOPÉRATION POUR ACCÉLÉRER LE DÉVELOPPEMENT DES MATÉRIAUX POUR BATTERIES DE NOUVELLE GÉNÉRATION

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Arkema (Paris:AKE), un leader mondial des Matériaux de Spécialités, et Senior, un leader mondial des technologies de séparateurs pour batteries, ont signé un protocole d'accord afin de renforcer davantage leur coopération stratégique à long terme et de faire progresser ensemble l’innovation tout au long de la chaîne de valeur des batteries. Dans le cadre de cette collaboration stratégique, Arkema et Senior renforceront leur coopération techniq...
-

DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--DATROWAY Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy...
-

VSE Corporation Prices Upsized Public Offerings of Common Stock and Tangible Equity Units

MIRAMAR, Fla.--(BUSINESS WIRE)--VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services, announced today that it has priced its previously announced underwritten public offering of 3,989,362 shares of its common stock at a price to the public of $188.00 per share, representing approximately $750 million of shares of common stock, and its previously announced concurrent underwritten public offering of 8,000,000 of its 5...
-

Castles Technology expands services strategy with acquisition of MT Bilgi Teknolojileri-Istanbul-Türkiye

VÉLIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Castles Technology successfully acquires MT Bilgi Teknolojileri A.Ş. (MTBT)....
-

ACI Worldwide Report: Global Refund Volumes Surge 18% as Retailers Tighten Returns

OMAHA, Neb. & LONDON--(BUSINESS WIRE)--Annual refund volumes in the global retail sector increased 18.1 % in 2025, while refund value rose 12.7% year-on-year, according to ACI’s annual Global Ecommerce Report. ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, analysed billions of retail transactions worldwide as part of the study. Refund activity peaked sharply during the holiday season; November and December together accounted for approximately 20% of all refun...